文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous revascularization.
复制论文ID
分享
摘要
作者
参考文献
暂无分享,去
创建一个
P. Mohanty
|
M. Davies
|
R. Kerensky
|
M. Stecher
|
H. E. El Sayed
|
Hosam F. El Sayed
保存到论文桶